Cited by 155Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery SystemsDendrimers and Hyperbranched Polymers

Poly(Ethylene Glycol)–Polylactide Micelles for Cancer Therapy

Open access
Wang, Jixue, Li, Shengxian, Han, Yuping, Guan, Jingjing, Chung, Shirley, Wang, Chunxi, Li, Di·2018·Frontiers in Pharmacology

Abstract

For the treatment of malignancy, many therapeutic agents, including small molecules, photosensitizers, immunomodulators, proteins and genes, and so forth, have been loaded into nanocarriers for controllable cancer therapy. Among these nanocarriers, polymeric micelles have been considered as one of the most promising nanocarriers, some of which have already been applied in different stages of clinical trials. The successful advantages of polymeric micelles from bench to bedside are due to their special core/shell structures, which can carry specific drugs in certain disease conditions. Particularly, poly(ethylene glycol)-polylactide (PEG-PLA) micelles have been considered as one of the most promising platforms for drug delivery. The PEG shell effectively prevents the adsorption of proteins and phagocytes, thereby evidently extending the blood circulation period. Meanwhile, the hydrophobic PLA core can effectively encapsulate many therapeutic agents. This review summarizes recent advances in PEG-PLA micelles for the treatment of malignancy. In addition, future perspectives for the development of PEG-PLA micelles as drug delivery systems are also presented.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2018.00202

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Polymeric nanomicelles possess the merit of the EPR effect due to their small size, where they passively diffuse through the endothelial lining and remain at the site of inflammation owing to poor lymphatic drainage, thus releasing their payload at the specific site.

    “The polymeric nanomicelles possess the merit of the EPR effect due to their small size [92] where they passively diffuse through the endothelial lining and remain at the site of inflammation owing to poor lymphatic drainage, thus releasing their payload at the specific site.”

    From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [92]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, J., Li, S., Han, Y., Guan, J., Chung, S., Wang, C., & Li, D.
Affiliations
  • Chinese Academy of Sciences (CN)
  • Jilin University (CN)
  • First Hospital of Jilin University (CN)
  • University of Waterloo (CA)
Corresponding author
  • Han, Yuping
  • Guan, Jingjing
  • Li, Di
Venue
Frontiers in Pharmacology
Published
2018-03-08
Volume
9
Pages
202-202
ISSN
1663-9812 (ISSN-L)
OpenAlex
W2792803144
Cited by
155
References
115
Citations by year
2026: 7 · 2025: 13 · 2024: 26 · 2023: 21 · 2022: 22 · 2021: 20 · 2020: 24 · 2019: 16 · 2018: 5
FWCI
1.07
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (51673190, 51603204, 51303174, 51473165, 51390484, 51520105004)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
Keywords
polymeric micelles, cancer therapy, drug delivery systems, nanocarriers, core-shell structure, PEGylation, blood circulation, protein adsorption resistance, photosensitizers, gene delivery, clinical translation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review